Advertisement

Spinal Tech

ConMed has reported second quarter sales of $189.7 million, an increase of 3.5 percent compared to the same quarter last year.

A Delaware Chancery Court judge dismissed allegations that Synthes did not patiently shop or gain the highest price for Johnson & Johnson's $21.3 billion acquisition of the company, according to a Bloomberg Businessweek report.

Advertisement
Advertisement